Internal Medicine, Infectious Disease · Manhasset, NY
NPI
1689654840
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Community Dr
Manhasset, NY, 11030
Phone (516) 562-4188
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
337 services
Medicare patients, 2024
152
Average age 70
Drug cost, 2024
$8.9M
7,131 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph P McGowan was code 99214 (office e&m - established), 107 times for 63 patients. In total Joseph P McGowan billed 337 services in 32 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 107 | 63 | $92.66 | $9,915 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 50 | $71.42 | $3,785 |
| G0008 Administration of influenza virus vaccine | Office | 27 | 26 | $37.09 | $1,001 |
| 90662 Vaccine Product | Office | 21 | 21 | $81.35 | $1,708 |
| 99214 Office E&M - Established | Facility | 13 | 12 | $81.46 | $1,059 |
| G0009 Administration of pneumococcal vaccine | Office | 11 | 11 | $37.09 | $408 |
By year: 2022 $36K for 773 services; 2023 $30K for 392 services; 2024 $27K for 337 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph P McGowan prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 721 prescriptions and refills. In total Joseph P McGowan wrote 7,131 Medicare prescriptions that cost $8.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 721 | 731 | 80 | $2.8M |
| Tivicay Dolutegravir Sodium | 366 | 392 | 39 | $903K |
| Atorvastatin Calcium Generic | 321 | 372 | 42 | $1,050 |
| Descovy Emtricitabine/Tenofov Alafenam | 300 | 316 | 31 | $678K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 178 | 183 | 24 | $5,917 |
| Ritonavir Generic | 158 | 168 | 18 | $25K |
| Lisinopril Generic | 148 | 180 | 20 | $354 |
| Rosuvastatin Calcium Generic | 143 | 179 | 28 | $867 |
| Amlodipine Besylate Generic | 142 | 174 | 22 | $370 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 132 | 156 | 15 | $552K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 129 | 145 | 13 | $646K |
| Gabapentin Generic | 128 | 132 | 16 | $1,383 |
| Valacyclovir Valacyclovir Hcl | 118 | 170 | 21 | $4,773 |
| Pifeltro Doravirine | 101 | 101 | 11 | $167K |
| Rukobia Fostemsavir Tromethamine | 97 | 97 | Under 11 | $824K |
Brand drugs: 3,142 claims; generic drugs: 3,902 claims; opioid claims: 285.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph P McGowan $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.